Knee Osteoarthritis Market Industry Size, Opportunities and Forecast By 2029
"The significant Knee Osteoarthritis Market document employs calculations considering specific base and historic years, interpreting market performance in forecasted years. It informs about market definition, classifications, applications, and engagements. The report studies general market conditions, estimates a client company’s market share and possible sales volume, identifies the probable market for a new product launch, and discovers the most appropriate distribution method. Knee Osteoarthritis Market research report offers historic data alongside future forecasts and detailed analysis on a global and regional level.
A market research report, when prepared with the most up-to-date insights and analysis, provides maximum benefits to businesses. The Knee Osteoarthritis Market survey report studies trends in consumer and supply chain dynamics, aiding in the development of production strategies. It also provides company profiles, product specifications, production values, manufacturer contact information, and market shares. Through competitor analysis, businesses gain insights into key players' strategies, including new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions.
In recent years, the knee osteoarthritis market is anticipated to grow rapidly during the forecast period. According to the World Health Organization, around 10% to 15% of all persons over the age of 60 have osteoarthritis, with women having a higher prevalence than males. According to the United Nations, adults over the age of 60 will make up more than 20% of the global population by 2050. A conservative estimate of 15 percent of this 20 percent will have symptomatic osteoarthritis, with one-third of this cohort seriously afflicted. Knee osteoarthritis (OA), commonly known as the degenerative joint disease of the knee, is caused by wear and strain and gradual articular cartilage loss.
Data Bridge Market Research analyses that the knee osteoarthritis market was valued at USD 5.9 billion in 2021 and is expected to reach USD 12.02 billion by 2029, registering a CAGR of 9.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Explore Further Details about This Research Knee Osteoarthritis Market Report https://www.databridgemarketresearch.com/reports/global-knee-osteoarthritis-market
REPORT METRIC | DETAILS |
Forecast Period | 2022 to 2029 |
Base Year | 2021 |
Historic Years | 2020 (Customizable to 2019 - 2014) |
Quantitative Units | Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered | Treatment Type (Medication, Surgery, Therapy), Route of Administration (Oral, Parenteral, Others), Dosage Form (Tablets, Injections, Others), Diagnosis (Imaging Tests, Joint Fluid Analysis, Blood Tests, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) |
Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered | F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Zydus Cadila (India), Boehringer Ingelheim International GmbH. (Germany), Apotex Inc. (Canada), AstraZeneca (UK), Horizon Therapeutics PLC (Ireland), Johnson & Johnson (US), Bayer AG (Germany), Perrigo Company plc (Ireland), Tolmar Pharmaceuticals, Inc. (US), Reckitt Benckiser Group PLC (UK), Sun Pharmaceutical Industries Ltd. (India), Assertio Therapeutics, Inc. (US), DAIICHI SANKYO COMPANY, LIMITED (Japan) |
Market Opportunities |
|
Knee Osteoarthritis Market Dynamics
Drivers
- Increasing prevalence of osteoarthritis
The rising prevalence of osteoarthritis is estimated to enhance the knee osteoarthritis market's growth. Injury, obesity, and a variety of other factors contribute to osteoarthritis. The damaged bodily part has severe joint pain and stiffness. Swelling of joints, tingling in the legs and limbs, and a reduction in range of motion are all indications of osteoarthritis.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of the knee osteoarthritis market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
- Growing number of geriatric population
The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to knee osteoarthritis, further estimated to enhance the market's growth rate.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the knee osteoarthritis market. Additionally, rise in the incidences of knee osteoarthritis among the general population and sedentary lifestyle of people will result in the expansion of knee osteoarthritis market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the knee osteoarthritis market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the knee osteoarthritis market growth during the forecast period.
Key Benefits of the Report:
- This study presents the analytical depiction of the global Knee Osteoarthritis Market ndustry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Knee Osteoarthritis Market share.
- The current market is quantitatively analyzed from 2022 to 2029 to highlight the Knee Osteoarthritis Market growth scenario.
- Porter's five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Knee Osteoarthritis Market analysis based on competitive intensity and how the competition will take shape in coming years.
Browse Related Reports:
Typhoid Vaccine Market Size worth Billion Globally by Size, Share, Trends, Demand, Revenue Growth and Competitive Outlook
https://www.databridgemarketresearch.com/reports/global-typhoid-vaccine-market
Celiac Disease Market to Observe Prominent CAGR Growth by 2Size, Share, Trends, Demand, Market Growth and Competitive Analysis
https://www.databridgemarketresearch.com/reports/global-celiac-disease-market
Diabetic Macular Edema Market To Perceive Highest CAGR Growth by Size, Share, Trends, Key Drivers, Growth Opportunities and Revenue Analysis
https://www.databridgemarketresearch.com/reports/global-diabetic-macular-edema-market
cerebral cavernous malformation Market to Perceive Prominent Growth of Billion by Size, Share, Trends, Demand, Growth and Competitive Analysis
https://www.databridgemarketresearch.com/reports/global-cerebral-cavernous-malformation-market
Liposome Drug Delivery Market Forecasted to Exhibit an Incredible Growth of Billion by Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
https://www.databridgemarketresearch.com/reports/global-liposome-drug-delivery-market
HIV Market Anticipated to Garner Significant Growth of Billion By Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast
https://www.databridgemarketresearch.com/reports/global-hiv-market
Ovarian Cancer Market Poised to Achieve Exponential CAGR Growth by Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast
https://www.databridgemarketresearch.com/reports/global-ovarian-cancer-market
Healthcare Asset Management Market to Notice Prominent CAGR Growth by Size, Share, Trends, Demand, Growth and Competitive Outlook
https://www.databridgemarketresearch.com/reports/global-healthcare-asset-management-market
Prenatal Genetic Testing Market to Observe Utmost Growth of Billion by Size, Share, Trends, Demand, Key Players and Growth Factors
https://www.databridgemarketresearch.com/reports/global-prenatal-genetic-testing-market
Sarcoidosis Drug Market is Probable to Influence the Value of Billion by Size, Share, Trends, Growth and Competitive Outlook
https://www.databridgemarketresearch.com/reports/global-sarcoidosis-drug-market
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com
Comments
Post a Comment